13F
← All fund report cards

MEITAV INVESTMENT HOUSE LTD

13F equity value
$9.1B
Positions
232
Top 10 concentration
45.4%
Quarters / total new picks
32 / 774
13F equity value over time
$0M$5B$9B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.6% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = 1.47, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.9%
t-stat
1.47
Quarterly win rate
47%
Annualized excess
-0.5%
$1 → follow vs universe
$2.01 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.07720180630: follow 0.99920180930: follow 1.06420181231: follow 1.01220190331: follow 1.07220190630: follow 1.11620190930: follow 1.30220191231: follow 1.12820200331: follow 1.34720200630: follow 1.45920200930: follow 1.70020201231: follow 1.69920210331: follow 1.72220210630: follow 1.84720210930: follow 1.59520211231: follow 1.33620220331: follow 1.39020220630: follow 1.33820220930: follow 1.44720221231: follow 1.47020230331: follow 1.46720230630: follow 1.44020230930: follow 1.60520231231: follow 1.78020240331: follow 1.73020240630: follow 1.76420240930: follow 1.83920241231: follow 1.72120250331: follow 1.87220250630: follow 1.94320250930: follow 2.10820251231: follow 2.011 0.84 1.56 2.28 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 232 · 2026 Q1

Ticker Value Weight QoQ
SPY $1.0B
11.2%
ADD
QQQM $612M
6.7%
ADD
QQQ $363M
4.0%
TRIM
XLC $351M
3.9%
TRIM
SMH $347M
3.8%
ADD
ESLT $333M
3.6%
ADD
TSEM $308M
3.4%
TRIM
AMZN $282M
3.1%
ADD
NVDA $268M
2.9%
ADD
META $254M
2.8%
ADD
ENLT $248M
2.7%
TRIM
NVMI $247M
2.7%
ADD
XLV $233M
2.5%
TRIM
XLY $216M
2.4%
ADD
XLI $215M
2.4%
ADD
XLF $163M
1.8%
TRIM
XLU $158M
1.7%
ADD
ICL $152M
1.7%
ADD
EPI $142M
1.6%
ADD
V $136M
1.5%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.